We found the effects of SLC6A14 on tumor cell growth in vitro and tumorigenesis in vivo, and confirmed that Akt-mTOR signaling was activated in SLC6A14-mediated CRC progression. This evidence concerns the gene MTOR and colorectal carcinoma.